<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.funafutitechreport.com/article/904327011-emovid-launches-asynchronous-verified-human-communication-platform-to-combat-ai-generated-fraud</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T15:27:27+00:00</news:publication_date>
        <news:title>Emovid Launches Asynchronous Verified Human Communication Platform to Combat AI-generated Fraud</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a1d19c0b-6a54-43b5-a090-28213b903073/medium/verified-human-seal.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904318654-nextel-medical-corp-announces-pivotal-milestone-in-commercial-launch-of-patent-protected-nanog-dna-cancer-screening-test</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:30:00+00:00</news:publication_date>
        <news:title>NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZmQ2OTkwNDMtN2QzOS00OWQ1LThhYzctYzg5MzFjMjgwODMwLTUwMDE1ODM1Mi0yMDI2LTA0LTA3LWVu/tiny/Exousia-Pro-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904318466-bioora-and-octane-biotech-sign-letter-of-intent-to-expand-cell-therapy-manufacturing-using-the-cocoon-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:15:00+00:00</news:publication_date>
        <news:title>BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YzFhYmQ1NzYtNzA3My00Y2JiLWE2MGQtMjM3ZDBmYzMxNTJhLTEzMDQwMTAtMjAyNi0wNC0wNy1lbg==/tiny/Octane-Medical-Group.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904317864-esker-partners-with-ecovadis-to-deliver-enhanced-supplier-evaluation-capabilities</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:08:00+00:00</news:publication_date>
        <news:title>Esker Partners with EcoVadis to Deliver Enhanced Supplier Evaluation Capabilities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/8f31e510-1cce-4ae1-9351-21ceb934a40b/small/esker-corporate-logo-c-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904317940-just-badge-research-uncovers-why-employers-can-t-find-ai-talent-they-never-check-for-it</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:00:00+00:00</news:publication_date>
        <news:title>Just Badge Research Uncovers Why Employers Can&#39;t Find AI Talent — They Never Check for It</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3224691/cover-detection-gap-new.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904318003-the-ai-gap-in-automotive-retail-dealers-embrace-ai-but-say-it-falls-short-where-it-matters-most</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:00:00+00:00</news:publication_date>
        <news:title>The AI Gap in Automotive Retail: Dealers Embrace AI, But Say It Falls Short Where It Matters Most</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/485e88f0-2d15-4141-9e5e-fcc90f793ffc/small/lotlinx-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904318049-eso-acquires-d2i-accelerating-emergency-intelligence-to-drive-performance-and-improve-outcomes-across-fire-ems-and-health-systems</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:00:00+00:00</news:publication_date>
        <news:title>ESO Acquires d2i, Accelerating Emergency Intelligence to Drive Performance and Improve Outcomes across Fire, EMS and Health Systems </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c3be28a3-8e6b-472f-9262-89d9e19d3f5c/small/eso-logo-rgb-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904318054-vmake-launches-faster-ai-ugc-workflows-for-high-gmv-shoppable-videos-during-spring-sale</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:00:00+00:00</news:publication_date>
        <news:title>Vmake Launches Faster AI UGC Workflows for High-GMV Shoppable Videos During Spring Sale</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/700ba7c4-1a82-48e6-ae6a-6a2b9c851633/medium/vmake-ai-ugc-workflow.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904318197-orgn-introduces-cryptographically-secured-development-for-regulated-sensitive-enterprises</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:00:00+00:00</news:publication_date>
        <news:title>ORGN Introduces Cryptographically Secured Development for Regulated, Sensitive Enterprises</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/97d0c95f-4e90-41e0-9192-c25317a096fb/medium/orgn-dev.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309570-visionary-holdings-inc-announces-receipt-of-nasdaq-continued-listing-deficiency-letter</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:31:00+00:00</news:publication_date>
        <news:title>Visionary Holdings Inc. Announces Receipt of Nasdaq Continued Listing Deficiency Letter</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MzE0MmU2N2UtNTgwMi00MjBlLWFhOTctNmU2ZGUwM2Q0ZTE1LTEzMTczMjYtMjAyNi0wNC0wNy1lbg==/tiny/Visionary-Holdings-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308612-pixability-appoints-creator-economy-leader-jamie-gutfreund-to-advisory-board</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:30:00+00:00</news:publication_date>
        <news:title>Pixability Appoints Creator Economy Leader Jamie Gutfreund to Advisory Board</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2b3e957b-4c99-4de3-88e0-cd781d24b955/small/pixability-logo-red-4-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310032-almondnet-intent-iq-and-datonics-announce-resolution-of-patent-infringement-dispute-with-amazon</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:30:00+00:00</news:publication_date>
        <news:title>AlmondNet, Intent IQ and Datonics Announce Resolution of Patent Infringement Dispute with Amazon</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/69e00579-e0a4-48f3-9bfe-51980afc67b0/small/intentiq-logo-042722-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310228-merakris-therapeutics-provides-fda-update-and-reports-interim-findings-for-mtx-001-in-venous-leg-ulcers</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:30:00+00:00</news:publication_date>
        <news:title>Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5b9c5fed-3332-4d4d-b8b6-6ab1b15faaed/small/mrks-brand-logo-final-fullcolor-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310586-mext-introduces-ai-driven-memory-optimization-to-help-curb-rising-infrastructure-costs</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:30:00+00:00</news:publication_date>
        <news:title>MEXT Introduces AI-Driven Memory Optimization to Help Curb Rising Infrastructure Costs</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NGJlY2NlOWItNjE2Zi00NmQzLWJmMzktNTRiMDMwODRjYjUwLTEzMjI0MTMtMjAyNi0wNC0wNy1lbg==/tiny/MEXT.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310599-exelon-s-finance-transformation-success-with-powerplan-to-be-showcased-at-oracle-customer-edge-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:28:18+00:00</news:publication_date>
        <news:title>Exelon&#39;s Finance Transformation Success with PowerPlan to be Showcased at Oracle Customer Edge Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/53346dab-9ebc-46b8-8707-d804f8b7f100/small/powerplan-logo-1200x630-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310391-nurexone-biologic-s-u-s-subsidiary-exo-top-and-florida-based-bioxtek-sign-strategic-loi-for-exosome-manufacturing-and-commercialization</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:18:00+00:00</news:publication_date>
        <news:title>NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1514c671-cc84-4bcb-82d7-b834fce40882/small/nurexone-logo-rebrand-large-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308717-cellution-biologics-inc-announces-official-entry-into-the-ocular-market-at-ascrs-with-the-launch-of-opticover</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:11:00+00:00</news:publication_date>
        <news:title>Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch of OptiCover™</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/10957e60-6696-483a-9df0-88f8713da811/medium/opticover.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310226-syncfusion-announces-essential-studio-2026-volume-1</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:07:00+00:00</news:publication_date>
        <news:title>Syncfusion Announces Essential Studio 2026 Volume 1</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f3850a8d-19b2-4c5d-9931-98962da36a68/small/frame-5-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308746-toyota-leasing-thailand-upgrades-to-latest-wholesale-finance-system-on-netsol-s-transcend-finance-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:06:00+00:00</news:publication_date>
        <news:title>Toyota Leasing Thailand upgrades to latest Wholesale Finance System on NETSOL’s Transcend Finance platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8a9cd86b-b904-4a20-a55d-9bc05eaca7a6/small/netsol-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309067-picus-security-wins-gold-in-bas-and-ctem-categories-in-2026-cybersecurity-excellence-awards</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:03:00+00:00</news:publication_date>
        <news:title>Picus Security Wins Gold in BAS and CTEM Categories in 2026 Cybersecurity Excellence Awards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f86a8a55-0c0f-4460-86d9-4b577ed8cc28/small/picus-logo-original-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309365-talk-to-your-warehouse-autoscheduler-ai-announces-integration-of-voice-capabilities-and-explainable-ai-into-warehouse-decision-agent</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:03:00+00:00</news:publication_date>
        <news:title>Talk to Your Warehouse: AutoScheduler.AI Announces Integration of Voice Capabilities and Explainable AI into Warehouse Decision Agent</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f021eb47-2a5d-48f8-97d7-2e16aafbd296/small/as-all-green-vt-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308879-coder-ranks-15th-on-the-2026-inc-5000-list-of-the-fastest-growing-private-companies-in-the-southwest</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:02:00+00:00</news:publication_date>
        <news:title>Coder Ranks 15th on the 2026 Inc. 5000 List of the Fastest-Growing Private Companies in the Southwest</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f980e320-6962-447f-8933-d8819a4908f0/small/coder-logo-new-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309059-introducing-seven-falls-hold-co-a-new-era-for-mission-driven-software-impact</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:01:00+00:00</news:publication_date>
        <news:title>Introducing Seven Falls Hold Co.: A New Era for Mission-Driven Software Impact</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1157b3e9-0b26-419b-8eff-6edc56e4298e/small/7-falls-logo-full-color-positive-large-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308553-cangrade-research-analyzes-70-000-candidate-assessments-to-reveal-top-strengths-and-weaknesses-among-gen-z-and-millennial-workers</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Cangrade Research Analyzes 70,000+ Candidate Assessments to Reveal Top Strengths and Weaknesses among Gen Z and Millennial Workers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e3bc045a-7a1f-466b-a408-e3ccd5ab2417/small/cangrade-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308718-cloudbolt-research-exposes-the-trust-gap-blocking-kubernetes-optimization</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>CloudBolt Research Exposes the “Trust Gap” Blocking Kubernetes Optimization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e7c6a96c-eec9-443c-a04d-1a8a51528d44/small/cloudbolt-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308724-new-report-details-lack-of-support-for-black-led-nonprofits-following-2020-racial-justice-movement</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>New report details lack of support for Black-led nonprofits following 2020 racial justice movement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7fd2ff1d-9d99-4a03-8592-16495aa2befc/small/candid-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308956-pathai-and-medstar-health-announce-partnership-to-deploy-the-aisight-dx-digital-pathology-platform-and-advanced-ai-applications</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ab2bfc12-ae80-47c6-9345-a98783489ed7/small/pathai-logo-standard-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308983-midstream-health-deploys-ai-native-financial-intelligence-across-houston-methodist-s-enterprise-operations</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Midstream Health Deploys AI-Native Financial Intelligence Across Houston Methodist’s Enterprise Operations</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c25b5069-fa73-48a2-95a1-40626fb29608/small/midstream-black-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309052-colligo-and-carahsoft-partner-to-deliver-compliant-email-manager-software-to-the-public-sector</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Colligo and Carahsoft Partner to Deliver Compliant Email Manager Software to the Public Sector</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309072-new-research-reveals-busy-is-not-the-same-as-profitable-for-commercial-landscaping-contractors-in-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>New Research Reveals Busy Is Not the Same as Profitable for Commercial Landscaping Contractors in 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84d3bfb7-3716-43b4-825a-b25a7824d6c4/small/servicetitan-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309085-alation-appoints-rick-baker-as-chief-operating-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Alation Appoints Rick Baker as Chief Operating Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9c890af-27bf-4963-9e35-2d4362109249/medium/rick-baker-alation-coo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309128-car-buyers-are-changing-lanes-cargurus-reveals-where-consumers-are-finding-value</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Car Buyers are Changing Lanes: CarGurus Reveals Where Consumers are Finding Value</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e9ed825-143d-405a-9794-acd1a1ded2cc/small/cg-logo-2025-small-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309191-servicetitan-report-finds-74-of-residential-contractors-see-ai-as-key-to-efficiency-as-industry-shifts-toward-execution-led-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>ServiceTitan Report Finds 74% of Residential Contractors See AI as Key to Efficiency as Industry Shifts Toward Execution-Led Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84d3bfb7-3716-43b4-825a-b25a7824d6c4/small/servicetitan-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309259-asus-announces-all-new-zenbook-lineup-now-available-in-the-united-states</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>ASUS Announces All-New Zenbook Lineup, Now Available in the United States</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3225774/Zenbook-A16-scenario-photo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309348-blackpoint-cyber-releases-2026-threat-report</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Blackpoint Cyber Releases 2026 Threat Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cd2917e0-d1fa-4c31-b391-f3b9c681fde7/small/blackpoint-cyber-logo-v-fullcolor-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309376-dryrun-security-named-a-high-performer-in-sast-in-spring-2026-g2-reports</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>DryRun Security Named a High Performer in SAST in Spring 2026 G2 Reports</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/82dfad0c-82bf-4e08-94d5-fbb56397ca57/small/drs-logo-xlarge-green-black-light-bkgd-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309380-digits-introduces-outcome-based-pricing-for-accounting-sierra-s-head-of-sales-joins-as-strategic-advisor</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Digits Introduces Outcome-Based Pricing for Accounting; Sierra’s Head of Sales Joins as Strategic Advisor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/87400c33-e783-4a04-a9a1-c05320680f20/medium/digits-introduces-outcome-based-pricing-for-accounting.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309515-project44-launches-network-operations-agent-to-maintain-visibility-compliance-and-improve-data-accuracy</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>project44 Launches Network Operations Agent to maintain visibility compliance and improve data accuracy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0d6ce1c0-f0e7-453d-94ab-ba4bb33381b6/small/project-44-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310188-opkey-research-exposes-the-cloud-velocity-crisis-enterprises-struggle-to-keep-up-with-pace-of-change</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Opkey Research Exposes the Cloud Velocity Crisis: Enterprises Struggle to Keep Up with Pace of Change</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NzhlYzAzNDAtNjZlMi00NzViLTlmY2MtYTU4OGMyMTdmODQzLTEzMTc2OTgtMjAyNi0wNC0wNy1lbg==/tiny/Opkey.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310402-entrata-partners-with-agora-to-expand-investment-management-capabilities-for-multifamily-owners</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Entrata Partners with Agora to Expand Investment Management Capabilities for Multifamily Owners</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZTFiODBhM2YtZjZiZS00MDg1LTliZGQtMmM4NmU0Y2VkODcxLTUwMDE1ODUxNC0yMDI2LTA0LTA3LWVu/tiny/Entrata.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310437-arctic-wolf-named-a-2026-gartner-peer-insights-customers-choice-for-managed-detection-and-response</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Arctic Wolf Named a 2026 Gartner® Peer Insights™ Customers’ Choice for Managed Detection and Response</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/62df1097-f4bf-4e0a-af8a-9ce79bf1257b/small/arctic-wolf-company-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310457-minimus-appoints-tech-dealmaker-yael-nardi-as-chief-business-officer-to-drive-hyper-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Minimus Appoints Tech Dealmaker Yael Nardi as Chief Business Officer to Drive Hyper-Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1fb74f68-c95e-4c79-9bf1-abbae31d4580/medium/minimus-appoints-tech-dealmaker-yael-nardi-as-chief-business.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310454-edgemode-secures-strategic-power-partnership-to-accelerate-multi-gw-ai-data-center-development</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:51:13+00:00</news:publication_date>
        <news:title>EdgeMode Secures Strategic Power Partnership to Accelerate Multi-GW AI Data Center Development</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0680956a-e84d-46d0-bd43-a7b9593a52dc/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309350-outlook-therapeutics-announces-formal-dispute-resolution-request-for-ons-5010-lytenava-bevacizumab-vikg-accepted-by-fda</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:50:00+00:00</news:publication_date>
        <news:title>Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904309033-orbit-international-reports-consolidated-bookings-for-first-quarter-2026-in-excess-of-6-000-000</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:45:00+00:00</news:publication_date>
        <news:title>Orbit International Reports Consolidated Bookings for First Quarter 2026 in Excess of $6,000,000  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ea498c68-7dc2-4719-b2b2-f506dee887c9/small/orbit-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310501-redcloud-appoints-prof-dr-mustafa-ergen-to-board-as-non-executive-director-strengthening-ai-and-t-rkiye-expansion-strategy</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:45:00+00:00</news:publication_date>
        <news:title>RedCloud Appoints Prof. Dr. Mustafa Ergen to Board as Non-Executive Director, Strengthening AI and Türkiye Expansion Strategy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7cee46d3-852d-4da2-9bb4-e2d4bff8eb88/medium/prof-dr-mustafa-ergen.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904310366-vivopower-appoints-former-microsoft-global-ai-business-leader-and-g42-executive-khadija-mustafa-to-advisory-council</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:38:00+00:00</news:publication_date>
        <news:title>VivoPower Appoints Former Microsoft Global AI Business Leader and G42 Executive, Khadija Mustafa, to Advisory Council</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/372e7e36-8f34-46d9-8cbc-c2284310ed5f/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904308798-moleculin-releases-next-ceo-corner-segment-highlighting-annamycin-s-non-cardiotoxic-profile</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:36:00+00:00</news:publication_date>
        <news:title>Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299971-20-20-biolabs-selected-by-evexia-diagnostics-to-offer-onetest-for-cancer-through-evexia-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:31:00+00:00</news:publication_date>
        <news:title>20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300040-helport-ai-launches-ai-powered-collections-initiative-with-leading-asian-consumer-finance-company</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:31:00+00:00</news:publication_date>
        <news:title>Helport AI Launches AI-Powered Collections Initiative with Leading Asian Consumer Finance Company</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4165bcbe-7c28-4ab2-a6fa-6df96179cf81/small/helport-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299639-commercial-building-security-sensor-shipments-to-reach-352-million-by-2032-as-ai-and-retrofit-demand-accelerate-market-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Commercial Building Security Sensor Shipments to Reach 352 Million by 2032 as AI and Retrofit Demand Accelerate Market Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b2504449-ef14-41b7-b036-7b19dea47a19/small/abi-research-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299796-abeona-therapeutics-announces-appointment-of-keith-a-goldan-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299805-securetech-innovations-nominates-robert-v-castro-cpa-cgma-to-board-of-directors-and-audit-committee</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>SecureTech Innovations Nominates Robert V. Castro, CPA, CGMA, to Board of Directors and Audit Committee</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1f711eb4-3ed0-475a-9bc0-c8c2be33cbd0/small/securetech-m-l-securetech-logo-primary-r-exact-lines-may-202.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299929-doubleverify-to-announce-first-quarter-2026-financial-results-on-may-6-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>DoubleVerify to Announce First Quarter 2026 Financial Results on May 6, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/733b3b9c-c4d5-4069-b11e-6950f65bb1be/small/dv-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299997-thrive-launches-cjis-approved-hosting-capability-for-public-safety-agencies</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Thrive Launches CJIS-Approved Hosting Capability for Public Safety Agencies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fcaf797c-9107-49f6-bd64-eeb1f1ad37b1/small/thrive-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300074-cormedix-to-participate-in-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>CorMedix to Participate in Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb/small/crmd-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300165-milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300174-zenatech-initiates-plans-for-a-ukraine-testing-facility-for-drone-testing-and-operational-validation-of-its-interceptor-defense-systems</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>ZenaTech Initiates Plans for a Ukraine Testing Facility for Drone Testing and Operational Validation of its Interceptor Defense Systems</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/76d0c807-d331-4d2f-94f8-1697c3623a8f/small/zenatech-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300176-ai-enhanced-robotics-in-pharma-manufacturing-signals-major-efficiency-margin-expansion-opportunities</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/45ff7033-6ad2-41ba-bbd1-912eb2907b3e/small/ainewswire-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300182-ai-driven-compliance-gamechanger-in-pharma-manufacturing-and-regulatory-standards</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/45ff7033-6ad2-41ba-bbd1-912eb2907b3e/small/ainewswire-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300224-cycurion-amends-complaint-to-identify-individual-behind-anonymous-defamatory-campaign-on-stocktwits-and-reddit-investigation-continues</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Cycurion Amends Complaint to Identify Individual Behind Anonymous Defamatory Campaign on Stocktwits and Reddit; Investigation Continues</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YjM2ZWY3ZmEtNDQyMy00Yjc5LWFkZjctMTljOGVhNzE1YWE4LTEzMTA0NTAtMjAyNi0wNC0wNy1lbg==/tiny/Cycurion.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300233-cdt-notes-sarborg-publication-of-prism-framework-expanding-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>CDT Notes Sarborg Publication of PRISM Framework Expanding AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MjNiMmZlYjctZjk3NS00MWViLThkMjktZWUwZGQ1YzVkNzRjLTEyNzQxMDItMjAyNi0wNC0wNy1lbg==/tiny/CDT-Equity-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299831-biorestorative-therapies-announces-strategic-collaboration-with-203-creates-to-build-and-commercialize-biocosmeceutical-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:15:00+00:00</news:publication_date>
        <news:title>BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299713-nextcure-receives-fast-track-designation-for-sim0505-cdh6-adc-in-ovarian-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:05:00+00:00</news:publication_date>
        <news:title>NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299635-from-checks-to-systems-regula-recognized-across-key-layers-of-identity-verification-in-2026-cybersecurity-excellence-awards</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:01:00+00:00</news:publication_date>
        <news:title>From Checks to Systems: Regula Recognized Across Key Layers of Identity Verification in 2026 Cybersecurity Excellence Awards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7d1c4880-0c7d-4407-bdbb-90534ae8d14f/medium/cybersecurity-excellence-awards.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299511-evaxion-announces-last-patient-visit-in-one-year-extension-of-phase-2-trial-with-personalized-cancer-vaccine-evx-01</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299582-truecommerce-drives-faster-smarter-trade-with-new-agentic-ai-powered-platform-innovations</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>TrueCommerce Drives Faster, Smarter Trade with New Agentic AI-Powered Platform Innovations</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/424743f7-462d-4b03-a3a8-773a35b57f56/small/tc-logo-0917-3-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299584-naitiv-launches-as-the-first-ai-native-servicenow-consultancy</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Naitiv Launches as the First AI-Native ServiceNow Consultancy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YjM1MTYyNTAtM2FmZS00YTVkLWJkOWMtZTVkYWRmYjU0NDMwLTEzMjIyMTgtMjAyNi0wNC0wNy1lbg==/tiny/Naitiv-Partners.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299596-teleport-named-to-citizens-securities-2026-cyber-66-list-of-the-hottest-privately-held-cybersecurity-companies</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Teleport Named to Citizens Securities&#39; 2026 Cyber 66 List of the Hottest Privately Held Cybersecurity Companies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/67d89922-be62-4d0c-9bde-f3e82a817328/small/teleport-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299599-acronis-launches-mdr-by-acronis-tru-to-provide-24-7-threat-detection-and-response-for-msps</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Acronis Launches MDR by Acronis TRU to Provide 24/7 Threat Detection and Response for MSPs</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/986ccfdd-5646-4d82-ad35-416f6228d899/medium/acronis-launches-mdr-by-acronis-tru.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299601-lyell-immunopharma-announces-participation-in-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fa4a7bb1-f8ea-45e7-ba51-37077689a4fb/small/lyell-branding-color-rgb-102918a-copy-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299636-micropolis-to-participate-in-maxim-group-s-ai-infrastructure-virtual-conference-on-april-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Micropolis to Participate in Maxim Group’s AI Infrastructure Virtual Conference on April 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/50a7adfb-02e7-4c3a-817c-ac39b63f8b4b/small/micropolis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299670-aptean-brings-agentic-ai-to-supply-chain-planning-with-logility-demandai-on-aptean-appcentral</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Aptean Brings Agentic AI to Supply Chain Planning with Logility DemandAI+ on Aptean AppCentral</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2246c26d-451a-4606-8d5c-ae8e19f259f0/small/aptean-logo-black-150ppi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299705-inhibikase-therapeutics-announces-enrollment-of-first-patient-in-improve-pah-global-phase-3-study-of-ikt-001-in-the-treatment-of-pulmonary-arterial</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/32b8d8bc-ebf8-43c0-866a-6613b22263b1/small/ikt-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299752-amneal-announces-2-million-donation-to-support-patient-access-to-essential-medicines-during-parkinson-s-awareness-month</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299819-yprime-expands-ecoa-platform-with-participant-hub</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>YPrime Expands eCOA Platform with Participant Hub</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f1e563ef-ebee-4900-b5f2-f80f89966a46/medium/yprime-expands-ecoa-platform-with-participant-hub.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299826-ip-strategy-highlights-aria-s-frontline-k-pop-release-with-rescene-on-story</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>IP Strategy Highlights Aria’s Frontline K-Pop Release with RESCENE on Story</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9d78839f-c938-4eb2-ae11-0f1ba1174b80/small/ipstrategylogo4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299830-crispr-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299833-gatc-health-and-uc-irvine-announce-landmark-pnas-publication-validating-ai-platform-for-opioid-use-disorder-treatment</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>GATC Health and UC Irvine Announce Landmark PNAS Publication Validating AI-Platform for Opioid Use Disorder Treatment</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8252f5cc-6aca-4b39-b708-845c0ce98b86/small/color-logo-vector-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299836-alphasense-scales-global-operations-to-meet-surging-demand-for-applied-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>AlphaSense Scales Global Operations to Meet Surging Demand for Applied AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZTk1YWJiZWQtYjUyYy00ZjE2LThiYTItN2Y4NzNiNWFkNzA4LTEyNDAzOTQtMjAyNi0wNC0wNy1lbg==/tiny/AlphaSense.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299844-armada-and-carahsoft-open-first-galleon-experience-center-at-carahsoft-headquarters</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Armada and Carahsoft Open First Galleon Experience Center at Carahsoft Headquarters</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299849-valitor-announces-oral-presentation-at-the-upcoming-association-for-research-in-vision-and-ophthalmology-arvo-2026-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299853-route-92-medical-announces-50-million-growth-financing</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Route 92 Medical Announces $50 Million Growth Financing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/526036da-ddbe-4a9a-9222-9570f7cd6544/small/r-rt92-logo-rbg0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300025-calidi-biotherapeutics-announces-speaker-presentation-at-asgct-conference-in-boston-on-may-14-2026-highlighting-the-redtail-platform-s-ability-to</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300035-visionwave-holdings-inc-successfully-participates-in-the-91st-emerging-growth-conference-full-presentation-now-available-for-replay</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>VisionWave Holdings, Inc. Successfully Participates in the 91st Emerging Growth Conference; Full Presentation Now Available for Replay</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a5316c97-32c7-4b3e-b330-b3fe019bd5c9/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300073-corbus-pharmaceuticals-announces-broad-alignment-with-fda-on-registration-path-for-crb-701-in-second-line-hnscc-and-cervical-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300079-seon-appoints-jules-gsell-of-ivp-to-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>SEON Appoints Jules Gsell of IVP to Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8fd4ac28-222b-467c-9be5-e2d4b3fb2974/small/seonlogo-rgb-green-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300089-liquidia-corporation-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Liquidia Corporation to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f7659070-cc55-4e68-ae70-33013e7df72c/small/liquidia-new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300137-ttec-advances-its-commitments-to-employee-well-being-and-environmental-stewardship-in-its-latest-impact-and-sustainability-report</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>TTEC Advances Its Commitments to Employee Well-Being and Environmental Stewardship in Its Latest Impact and Sustainability Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8488146d-993c-40c8-8d4c-b993aa023cb2/small/screenshot-2025-10-17-132937-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300151-electrocore-announces-first-patient-enrollment-in-investigator-led-study-of-gammacore-nvns-for-ptsd</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300194-bitbase-officially-launches-globally-hinting-at-ecosystem-credentials-for-professional-traders</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Bitbase Officially Launches Globally, Hinting at &quot;Ecosystem Credentials&quot; for Professional Traders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/eaf51f3f-3135-48e9-a608-730194cad4d9/medium/bitbase.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300247-nowvertical-expands-strategic-engagement-with-global-information-services-company-surpassing-2-8m-signed-in-first-year</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>NowVertical Expands Strategic Engagement with Global Information Services Company, Surpassing $2.8M Signed in First Year</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7b67b6ed-ec53-4a2f-ac00-10d021f41afa/small/nowvertical-logofinal-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300262-vertex-advances-ai-powered-capabilities-to-improve-how-enterprises-execute-compliance</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Vertex Advances AI-Powered Capabilities to Improve How Enterprises Execute Compliance</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6ba021ca-eeeb-4dd6-8e42-23f8fc2008eb/small/vertex-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300354-jupiter-neurosciences-appoints-kristopher-fishman-and-sanjiv-lal-to-nugevia-advisory-board</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300403-polyrizon-ltd-announces-3-5-million-registered-direct-offering-and-private-placement</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/N2M3NTE1MmItYWFmMi00MDNlLWE4MTItMWIxMDg4MWYwMTRlLTUwMDEyOTIyMy0yMDI2LTA0LTA3LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300175-artelo-biosciences-regains-compliance-with-nasdaq-listing-requirements</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:50:00+00:00</news:publication_date>
        <news:title>Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/460502d7-b0d3-43d8-a15a-5b2bb963bbbb/small/artelo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300171-galveston-police-department-adopts-non-lethal-response-solutions-with-purchase-of-bolawrap-devices-and-wraptactics-subscription-supported-by</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:45:00+00:00</news:publication_date>
        <news:title>Galveston Police Department Adopts Non-Lethal Response Solutions with Purchase of BolaWrap® Devices and WrapTactics™ Subscription, Supported by In-Person Training as Part of Broader NLR Strategy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4bb925f9-68c4-4202-b586-7437078944f3/small/yahoo-finance-wrap-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300189-lk-tech-appoints-matthew-marker-kump-as-chief-revenue-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:44:00+00:00</news:publication_date>
        <news:title>LK Tech Appoints Matthew Marker-Kump as Chief Revenue Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1dee9f0c-c628-4adf-8374-878fdeb4fd16/small/lk-tech-logo-white-2-png.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299627-marvel-biosciences-secures-financial-and-strategic-investment-with-5-horizon-ventures</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d49e32dc-88d9-4694-a3dd-6e663548e80d/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299841-plus-therapeutics-receives-ama-pla-code-for-cnside-csf-tumor-cell-enumeration-test-advancing-reimbursement-and-u-s-commercial-adoption</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904299993-cognition-therapeutics-to-present-at-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Cognition Therapeutics to Present at Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a14fd627-7ccb-45e2-95fe-792bbfb83231/small/2020-0227-cognition-logo-for-gnw-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300109-cervomed-to-provide-neflamapimod-clinical-program-update-and-participate-in-a-panel-on-biomarkers-at-2026-lewy-body-dementia-association-annual</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/332fd58e-5e2b-4c96-8eaf-719ac2e34f52/small/cervomed-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904300157-nervgen-pharma-announces-successful-end-of-phase-2-meeting-and-fda-alignment-on-restore-a-phase-3-registrational-study-of-nvg-291-for-chronic</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290025-neuroscale-ai-joins-hpe-unleash-ai-partner-program-to-bring-signal-based-agentic-recruiting-to-enterprise-ai-deployments</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:23:00+00:00</news:publication_date>
        <news:title>Neuroscale AI Joins HPE Unleash AI Partner Program to Bring Signal-Based, Agentic Recruiting to Enterprise AI Deployments</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDlmZGMwMTctYmViNi00NzcwLWFmNTItZTFjMzM2MDExMWFmLTEzMjA5MjEtMjAyNi0wNC0wNy1lbg==/tiny/Neuroscale-AI.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290254-fennec-pharmaceuticals-announces-investigator-sponsored-study-to-be-conducted-by-university-of-arizona-cancer-center</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:03:00+00:00</news:publication_date>
        <news:title>Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290176-invivyd-launches-antibodies-for-any-body-in-partnership-with-world-champion-skier-lindsey-vonn-to-inspire-actions-that-help-support-immune-health</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:01:00+00:00</news:publication_date>
        <news:title>Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290028-ac-immune-announces-amendment-to-morphomer-tau-license-and-collaboration-agreement-with-lilly</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290055-mediwound-to-present-new-escharex-data-at-leading-wound-care-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>MediWound to Present New EscharEx® Data at Leading Wound Care Conferences </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290245-sionna-therapeutics-to-participate-in-the-raymond-james-2026-biotech-innovation-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290282-breckenridge-distillery-introduces-honey-whiskey-crafted-with-rare-nigerian-goldswarm-honey-a-must-try-for-whiskey-enthusiasts</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cb623008-0c9a-49db-ab38-6e3062dd8bdb/medium/breckenridge-distillery-honey-whiskey.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290354-climb-bio-announces-fda-fast-track-designation-for-budoprutug-for-the-treatment-of-primary-membranous-nephropathy</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290361-skye-bioscience-presenting-at-glp-1-based-therapeutics-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290381-nurix-therapeutics-to-participate-in-upcoming-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Nurix Therapeutics to Participate in Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/65f50366-0a4e-4329-b0f5-f737c6145524/small/new-primary-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290410-fortrea-unveils-fortrea-intelligent-technology-to-help-sponsors-and-sites-run-smarter-more-integrated-trials</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9fbbe00b-8782-464e-83e6-5843c563884a/small/fortrea-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290597-neuronetics-comments-on-letter-from-pointillist-family-office</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Neuronetics Comments on Letter from Pointillist Family Office</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290600-okyo-pharma-announces-scientific-advisory-board-meeting-and-urcosimod-data-presentation-during-ascrs-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/23e4046d-dcf9-4dd1-945e-461e98a27d15/small/full-logo-okyo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290602-vantage-hemp-co-engages-acos-and-gpos-to-advance-participation-in-cms-cbd-pilot-program</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d38e4562-945b-4df7-8869-623c43be10f1/medium/inside-vantages-manufacturing-facility.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904289999-virtune-ab-publ-virtune-hat-die-neugewichtung-f-r-m-rz-2026-des-virtune-stablecoin-index-etp-durchgef-hrt</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:50:47+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) („Virtune“) hat die Neugewichtung für März 2026 des Virtune Stablecoin Index ETP durchgeführt</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290011-virtune-ab-publ-virtune-har-genomf-rt-rebalanseringen-f-r-mars-2026-av-virtune-stablecoin-index-etp</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:50:47+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (“Virtune”) har genomfört rebalanseringen för mars 2026 av Virtune Stablecoin Index ETP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290060-virtune-ab-publ-virtune-has-completed-the-rebalancing-for-march-2026-of-its-virtune-stablecoin-index-etp</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:50:47+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (&quot;Virtune&quot;) has completed the rebalancing for March 2026 of its Virtune Stablecoin Index ETP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290206-ani-pharmaceuticals-announces-publication-of-new-day-clinical-trial-results-in-ophthalmology</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:50:00+00:00</news:publication_date>
        <news:title>ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290013-equativ-hilft-werbetreibenden-die-aufmerksamkeit-der-zuschauer-durch-creative-enhancements-zur-ckzugewinnen</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:32:00+00:00</news:publication_date>
        <news:title>Equativ hilft Werbetreibenden, die Aufmerksamkeit der Zuschauer durch Creative Enhancements zurückzugewinnen</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/69906169-b35e-4eca-a7d5-871655b47a9e/ctv-shoppable-newpr-equativ-e.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290015-equativ-helps-advertisers-reclaim-viewer-attention-with-creative-enhancements</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:32:00+00:00</news:publication_date>
        <news:title>Equativ helps advertisers reclaim viewer attention with Creative Enhancements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/69906169-b35e-4eca-a7d5-871655b47a9e/ctv-shoppable-newpr-equativ-e.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290019-equativ-ayuda-a-los-anunciantes-a-recuperar-la-atenci-n-del-espectador-con-creative-enhancements</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:32:00+00:00</news:publication_date>
        <news:title>Equativ Ayuda a los Anunciantes a Recuperar la Atención del Espectador con Creative Enhancements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/69906169-b35e-4eca-a7d5-871655b47a9e/ctv-shoppable-newpr-equativ-e.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290068-equativ-aide-les-annonceurs-reconqu-rir-l-attention-des-t-l-spectateurs-gr-ce-aux-creative-enhancements</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:32:00+00:00</news:publication_date>
        <news:title>Equativ aide les annonceurs à reconquérir l’attention des téléspectateurs grâce aux Creative Enhancements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/69906169-b35e-4eca-a7d5-871655b47a9e/ctv-shoppable-newpr-equativ-e.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290069-equativ-aiuta-gli-inserzionisti-a-riconquistare-l-attenzione-degli-spettatori-con-i-creative-enhancements</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:32:00+00:00</news:publication_date>
        <news:title>Equativ Aiuta gli Inserzionisti a Riconquistare l&#39;Attenzione degli Spettatori con i Creative Enhancements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/69906169-b35e-4eca-a7d5-871655b47a9e/ctv-shoppable-newpr-equativ-e.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290525-boss-zhipin-continues-share-repurchases-with-total-repurchases-amounting-to-nearly-rmb700-million-in-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:30:00+00:00</news:publication_date>
        <news:title>BOSS Zhipin Continues Share Repurchases, with Total Repurchases Amounting to Nearly RMB700 Million in 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3983f407-fe67-4bb8-b418-feb895fdada1/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904290252-arastelle-joins-red-cat-futures-initiative-to-expand-persistent-isr-and-tactical-communications-capabilities</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:28:00+00:00</news:publication_date>
        <news:title>Arastelle Joins Red Cat Futures Initiative to Expand Persistent ISR and Tactical Communications Capabilities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ed315aba-089a-4cd6-893d-35620bd2b298/small/red-cat-defining-logo-lockup-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904280802-serina-therapeutics-to-present-at-the-5th-lnp-formulation-process-development-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>Serina Therapeutics to Present at the 5th LNP Formulation &amp; Process Development Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7f8e4304-8465-4d4d-a7e3-ebc4eae51f29/small/yellow-burts-blue-text-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904280810-ascellahealth-named-to-financial-times-americas-fastest-growing-companies-2026-list</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>AscellaHealth Named to Financial Times Americas’ Fastest Growing Companies 2026 List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5278c55f-330c-41a1-8446-d8b1a07bbc55/small/ah-logo-colornotag-4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904280821-greenwich-lifesciences-provides-update-on-patent-claims-potentially-doubling-gp2-market-potential</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904263002-oculis-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T08:00:00+00:00</news:publication_date>
        <news:title>Oculis to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904253282-earweiss-partners-with-usound-to-power-next-generation-hearables-with-mems-speaker-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T07:00:00+00:00</news:publication_date>
        <news:title>Earweiss Partners with USound to Power Next-Generation Hearables with MEMS Speaker Technology </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/836fd74e-23b1-446b-957f-c27e813fa184/medium/earweiss-and-usound-partner-to-bring-mems-speaker-technology.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904253286-samba-and-tivo-announce-strategic-partnership-to-transform-ctv-advertising-across-the-uk</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T07:00:00+00:00</news:publication_date>
        <news:title>Samba and TiVo Announce Strategic Partnership to Transform CTV Advertising Across the UK</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a74fa7-09fe-4ed7-8189-1587683af145/small/samba-tv-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904253341-sononeu-exits-stealth-as-key-part-of-us-government-funded-research-program-worth-up-to-41-3m-to-advance-sonogenetics-into-clinic</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T07:00:00+00:00</news:publication_date>
        <news:title>SonoNeu exits stealth as key part of US Government-funded research program worth up to $41.3m to advance sonogenetics into clinic</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/28b90f6b-ca31-4be4-92ca-1d1e341f55f3/small/sononeu-small-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904235360-press-release-sanofi-s-lunsekimig-met-primary-and-key-secondary-endpoints-in-phase-2-respiratory-studies-in-asthma-and-crswnp</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T05:00:00+00:00</news:publication_date>
        <news:title>Press Release:  Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904235375-communiqu-de-presse-le-lunsekimig-de-sanofi-a-atteint-les-crit-res-d-valuation-principal-et-secondaires-cl-s-dans-les-tudes-respiratoires-de-phase</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T05:00:00+00:00</news:publication_date>
        <news:title>Communiqué de presse: Le lunsekimig de Sanofi a atteint les critères d’évaluation principal et secondaires clés dans les études respiratoires de phase 2 dans l’asthme et la rhinosinusite chronique avec polypose nasale</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904203030-ryoncil-continues-successful-first-year-launch-with-net-sales-of-us-30-3m-in-march-quarter</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T01:03:58+00:00</news:publication_date>
        <news:title>Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904187967-q1-2026-strong-revenue-growth-and-therapeutics-pipeline-advancement</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T23:37:15+00:00</news:publication_date>
        <news:title>Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904187944-organogenesis-achieves-primary-endpoint-in-randomized-controlled-trial-of-puraply-am</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T23:02:29+00:00</news:publication_date>
        <news:title>Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904173823-crypto-news-alphapepe-ai-dex-demo-drops-soon-while-bitcoin-price-prediction-forecasts-125k</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T22:00:00+00:00</news:publication_date>
        <news:title>Crypto News: AlphaPepe AI DEX Demo Drops Soon While Bitcoin Price Prediction Forecasts $125K</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/643c21ed-c2a4-4219-8e4c-97d6acf5ce9f/medium/alphapepe-crypto-news.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904174110-renovare-therapeutics-inc-announces-company-launch-and-collaboration-with-cu-boulder-awardee-of-up-to-33-5-million-in-arpa-h-funding-to-advance</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:59:37+00:00</news:publication_date>
        <news:title>Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of up to $33.5 Million in ARPA-H Funding to Advance Osteoarthritis Regenerative Therapies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OTA0OGZiNjgtYTYzNi00MDUzLTk4YmYtYTMwMzBjYjVjMmNmLTEzMjIzODItMjAyNi0wNC0wNi1lbg==/tiny/Renovare-Therapeutics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904174055-altai-announces-transfer-of-listing-to-nex</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:48:29+00:00</news:publication_date>
        <news:title>Altai Announces Transfer of Listing to NEX</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/361de0c0-80ae-4b21-bd32-9f4f0c554031/small/altai-logo-hrjpg-gold-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904173827-avicanna-announces-changes-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:30:00+00:00</news:publication_date>
        <news:title>Avicanna Announces Changes to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904173889-organogenesis-announces-successful-fda-meeting-and-plan-to-file-bla-for-renu-for-knee-osteoarthritis-pain</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:30:00+00:00</news:publication_date>
        <news:title>Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904167577-nuvini-adquire-controle-de-51-dos-neg-cios-americanos-da-beyondsoft-corporation-estabelecendo-uma-plataforma-global-de-tecnologia-de-us-148-milh-es</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:08:12+00:00</news:publication_date>
        <news:title>Nuvini Adquire Controle de 51% dos Negócios Americanos da Beyondsoft Corporation, Estabelecendo uma Plataforma Global de Tecnologia de US$ 148 milhões</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/26401cd7-2d88-4e50-85ae-cedd5e8092dc/small/nuvini-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904167480-mawson-infrastructure-group-inc-provides-governance-update</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:00:00+00:00</news:publication_date>
        <news:title>Mawson Infrastructure Group Inc. Provides Governance Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1391467f-0125-4bad-8eb2-000e2a2be59b/small/mawson-black-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904161943-neuronetics-announces-chief-financial-officer-transition</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:30:00+00:00</news:publication_date>
        <news:title>Neuronetics Announces Chief Financial Officer Transition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904161867-silo-pharma-receives-european-patent-allowance-for-licensed-novel-ptsd-prevention-therapy</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:15:00+00:00</news:publication_date>
        <news:title>Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904161724-sprout-social-to-announce-first-quarter-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:05:00+00:00</news:publication_date>
        <news:title>Sprout Social to Announce First Quarter 2026 Financial Results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/478238bf-27b7-4275-b6c8-445cb1e39ab7/small/01-sprout-social-logo-lockup-main-4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904161913-immuneering-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:05:00+00:00</news:publication_date>
        <news:title>Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904161866-dianthus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:01:00+00:00</news:publication_date>
        <news:title>Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c9002285-2240-4dab-aced-77296f86a3fa/small/dianthus-logo-primary-full-color-cmyk-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904161983-ascendis-receives-orphan-drug-exclusivity-and-launches-yuviwel-navepegritide-in-the-united-states</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:01:00+00:00</news:publication_date>
        <news:title>Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904149419-syngas-obd-fuel-saver-review-2026-does-this-smart-device-actually-cut-your-fuel-costs</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T18:24:39+00:00</news:publication_date>
        <news:title>SynGas OBD Fuel Saver Review 2026: Does This Smart Device Actually Cut Your Fuel Costs? </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5d3e1700-4cfe-4353-8d7d-6587377be160/medium/syngas.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904143888-vicarius-nominated-for-best-b2b-branded-entertainment-video-film-in-the-30th-annual-webby-awards</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T18:12:00+00:00</news:publication_date>
        <news:title>Vicarius Nominated for Best B2B, Branded Entertainment Video &amp; Film in the 30th Annual Webby Awards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2c105e0e-13ef-454e-b55f-82d422767419/small/dark-full-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904138994-free-welcome-bonus-no-deposit-required-real-money-2026-free-spins-no-deposit-by-cafe-casino</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T17:31:32+00:00</news:publication_date>
        <news:title>Free Welcome Bonus No Deposit Required Real Money 2026 | Free Spins No Deposit By Cafe Casino</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6e3f1473-d22f-4a53-be7b-f5b855c87e13/medium/cafecasino.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904138903-no-deposit-casino-bonus-2026-free-spins-no-deposit-bonus-by-my-bookie</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T17:14:13+00:00</news:publication_date>
        <news:title>No Deposit Casino Bonus 2026 | Free Spins No Deposit Bonus By My Bookie</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/66b7c9ab-b1c7-4d10-b754-aaea8be62435/medium/mybookie.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904133990-telnyx-launches-livekit-on-telnyx-for-deploying-voice-ai-agents-with-lower-cost-and-ultra-low-latency</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T17:00:00+00:00</news:publication_date>
        <news:title>Telnyx Launches “LiveKit on Telnyx” for Deploying Voice AI Agents with Lower Cost and Ultra-Low Latency</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/dcacc2fc-90dc-4ca9-8834-1ee7f02c9148/small/telnyx-lockup-primary-one-color-green-large-copy-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904133910-taradel-unveils-data-driven-insights-from-1-000-campaigns-revealing-what-direct-mail-actually-converts</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T16:29:16+00:00</news:publication_date>
        <news:title>Taradel Unveils Data-Driven Insights from 1,000+ Campaigns, Revealing What Direct Mail Actually Converts</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4a498514-83d9-4f8a-8773-6eeda3338148/small/taradel-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904124490-jet-ai-inc-announces-reverse-stock-split</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T15:45:00+00:00</news:publication_date>
        <news:title>Jet.AI Inc. Announces Reverse Stock Split</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b81682ef-e4f9-4164-81f6-6ea3e3d45bb3/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904124434-biodesix-announces-aacr-2026-posters-and-presentations-highlighting-novel-diagnostic-test-discovery-pipeline-development</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T15:43:00+00:00</news:publication_date>
        <news:title>Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery &amp; Pipeline Development</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904124768-kaleris-recognized-as-inbound-logistics-2026-top-100-technology-provider</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T15:38:11+00:00</news:publication_date>
        <news:title>Kaleris Recognized as Inbound Logistics 2026 Top 100 Technology Provider</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c53942c1-e5c5-4fe3-a201-41a8b93632c0/small/kaleris-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904119809-crypfine-successfully-completes-travel-rule-integration-with-upbit-singapore</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T15:07:16+00:00</news:publication_date>
        <news:title>CrypFine Successfully Completes Travel Rule Integration with Upbit Singapore</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3e603805-9688-472f-87e9-04fa17bb6b80/small/screenshot-2026-04-06-103745-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904119613-yuzu-health-raises-35-million-series-a-to-modernize-health-insurance-plan-infrastructure</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T15:00:00+00:00</news:publication_date>
        <news:title>Yuzu Health Raises $35 Million Series A to Modernize Health Insurance Plan Infrastructure</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZTNkMDYxNWQtZmVjYS00M2RlLWI0OWYtMzA2MGY0YjhlN2E2LTEzMjIzODUtMjAyNi0wNC0wNi1lbg==/tiny/Yuzu-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904119743-clozer-launches-ai-powered-lead-generation-system-to-help-uae-businesses-acquire-more-clients</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:57:03+00:00</news:publication_date>
        <news:title>Clozer Launches AI-Powered Lead Generation System to Help UAE Businesses Acquire More Clients</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c30027f7-8efc-457d-b86d-11e0aa96139f/medium/closer-me.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904119717-celldex-therapeutics-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:53:52+00:00</news:publication_date>
        <news:title>Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904119708-yuno-launches-payments-concierge-an-always-on-ai-agent-for-payment-operations</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:53:28+00:00</news:publication_date>
        <news:title>Yuno Launches Payments Concierge: An Always-On AI Agent for Payment Operations</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a155b606-e4ed-4c1d-8b5f-91f3a57138bf/medium/yuno-launches-payments-concierge-an-always-on-ai-agent-for-p.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904111262-smartadvocate-earns-multiple-2026-software-advice-distinctions</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:00:00+00:00</news:publication_date>
        <news:title>SmartAdvocate Earns Multiple 2026 Software Advice Distinctions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3224505/SoftwareAdvicePressReleaseImage.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904111343-adaptin-bio-shares-to-be-quoted-on-the-otcqb-under-ticker-symbol-aptn</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:00:00+00:00</news:publication_date>
        <news:title>Adaptin Bio Shares to be Quoted on the OTCQB Under Ticker Symbol APTN</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/89fb59f4-0171-4319-995d-70be0b36378b/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904107250-zhengye-biotechnology-holding-limited-announces-implementation-of-dual-class-share-structure</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:25:00+00:00</news:publication_date>
        <news:title>Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9f44f819-7666-4ef0-b9e0-d50035c2a412/small/zybt-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904107196-curanex-highlights-patient-case-study-supporting-potential-of-phyto-n-in-cancer-cachexia-and-advanced-cancer-supportive-care</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:17:00+00:00</news:publication_date>
        <news:title>Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/29bc3de5-6a82-4a17-a165-6a79eef16d74/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904107248-maris-tech-expands-engagement-with-governmental-customer-in-intelligence-gathering-applications</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:10:00+00:00</news:publication_date>
        <news:title>Maris-Tech Expands Engagement with Governmental Customer in Intelligence Gathering Applications</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5d98827d-5fca-4beb-b603-08d5c973e3bd/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904103600-inspira-enters-quantum-computing-sector-targeting-a-critical-connectivity-bottleneck-with-newly-acquired-ame-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:01:00+00:00</news:publication_date>
        <news:title>Inspira Enters Quantum Computing Sector, Targeting a Critical Connectivity Bottleneck with Newly Acquired AME Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904103419-arizent-appoints-informa-techtarget-veteran-sean-matthews-to-lead-marketing-services</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Arizent Appoints Informa TechTarget Veteran Sean Matthews to Lead Marketing Services</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/dfe20092-4b13-4dbe-b3ad-8a259fdab516/medium/arizent.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904103434-paytronix-2026-loyalty-report-real-time-personalization-ai-powered-decisioning-drive-success</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Paytronix 2026 Loyalty Report: Real-Time Personalization &amp; AI-Powered Decisioning Drive Success</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a0a47d40-4419-436d-b187-246e25669b64/small/access-paytronix-dark-002-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904103443-oncolytics-biotech-announces-type-c-fda-meeting-to-discuss-single-arm-registrational-pathway-for-pelareorep-in-anal-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4dca5efc-ee4e-4e0a-b42d-7b45369d75da/small/oncy-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904103686-invary-and-carahsoft-partner-to-enhance-protection-against-zero-day-and-ai-driven-threats-for-government-agencies</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Invary and Carahsoft Partner to Enhance Protection Against Zero-Day and AI-Driven Threats for Government Agencies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904103518-akari-therapeutics-announces-strategic-partnership-with-wuxi-xdc-to-advance-development-of-its-novel-adc-payload-targeting-rna-splicing</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:45:00+00:00</news:publication_date>
        <news:title>Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904103580-nuvini-to-acquire-51-controlling-stake-in-the-american-business-of-beyondsoft-corporation-creating-a-148m-global-technology-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:40:00+00:00</news:publication_date>
        <news:title>Nuvini to Acquire 51% Controlling Stake in the American business of Beyondsoft Corporation, Creating a $148M Global Technology Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/26401cd7-2d88-4e50-85ae-cedd5e8092dc/small/nuvini-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904103589-pacific-office-automation-acquires-western-business-products-expanding-coverage-across-northern-california-and-southern-oregon</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:34:53+00:00</news:publication_date>
        <news:title>Pacific Office Automation Acquires Western Business Products, Expanding Coverage Across Northern California and Southern Oregon</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b59acb54-060b-4c1a-8ac1-760248b6a6e8/small/pacific-office-automation-logo-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904103416-gbt-technologies-announces-formation-of-cube-x-media-to-launch-national-digital-media-and-content-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:34:00+00:00</news:publication_date>
        <news:title>GBT Technologies Announces Formation of Cube X Media to Launch National Digital Media and Content Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1db63f00-e472-4422-a7ce-a353d7cab814/small/gbtlogo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904100094-inspira-technologies-announces-acquisition-of-the-ame-platform-from-nano-dimension</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:31:00+00:00</news:publication_date>
        <news:title>Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904100059-abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904100065-stablecoin-development-corporation-begins-trading-on-nyse-american-under-ticker-sdev</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:30:00+00:00</news:publication_date>
        <news:title>Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NDdlZTYyYTAtY2U1Ni00MzY2LWI2MTQtMDI5MDk0MDNhYjVkLTEwMjg2MTQtMjAyNi0wNC0wNi1lbg==/tiny/Stablecoin-Development-Corpora.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904100108-snail-games-expands-portfolio-with-publishing-agreement-for-co-op-party-action-title-dead-party</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:30:00+00:00</news:publication_date>
        <news:title>Snail Games Expands Portfolio with Publishing Agreement for Co-op Party Action Title Dead Party</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/be395172-b461-4e27-85f8-f4ab11cd12eb/small/snail-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904100113-nrsinsights-march-2026-retail-same-store-sales-report</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:30:00+00:00</news:publication_date>
        <news:title>NRSInsights’ March 2026 Retail Same-Store Sales Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6c3cc8f3-5363-4c09-a459-05237d45eb51/medium/sales.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096500-geron-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096522-levanta-acquires-perch-expanding-its-affiliate-marketplace-with-hundreds-of-amazon-sellers-and-publishers</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Levanta Acquires Perch+, Expanding Its Affiliate Marketplace with Hundreds of Amazon Sellers and Publishers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8aa3f292-a33b-467c-bbfb-de1b57d49d96/small/screenshot-2026-02-27-at-5-55-48-pm-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096550-avalyn-appoints-jon-congleton-seasoned-biopharmaceutical-executive-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096557-verrica-pharmaceuticals-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096643-tenvie-therapeutics-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-tnv262-a-fully-cns-penetrant-nlrp3-inhibitor</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV262, a Fully CNS-Penetrant NLRP3 Inhibitor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/311d9377-979c-4384-9258-5b496e854edb/small/tenvie-logo-gradient-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096651-phathom-pharmaceuticals-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096655-praxis-precision-medicines-announces-positive-results-from-the-embrave-part-a-trial-of-elsunersen-in-patients-with-scn2a-early-onset-developmental-and</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096679-commerce-announces-winners-of-apac-region-customer-and-partner-awards-honoring-exceptional-contributions-and-results-in-ecommerce</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Commerce Announces Winners of APAC Region Customer and Partner Awards Honoring Exceptional Contributions and Results in Ecommerce</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a953dd36-af2e-4b21-a5e8-45f93eb35143/small/commerce-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096684-magnite-to-announce-first-quarter-2026-financial-results-on-may-6-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Magnite to Announce First Quarter 2026 Financial Results on May 6, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YzMzMWViYTQtMjM4Ny00YTk4LTg4Y2YtMWVlZWNhYzg2YjI3LTEwMjkwMDQtMjAyNi0wNC0wNi1lbg==/tiny/Magnite-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096697-eaglenxt-announces-fifteen-unit-ebee-vision-order-from-u-s-army-unit-in-europe-expands-global-defense-deployment-footprint</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>EagleNXT Announces Fifteen-Unit eBee VISION Order from U.S. Army Unit in Europe, Expands Global Defense Deployment Footprint</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/896e875a-1cf3-4b04-b86e-ed1e70c43bda/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096792-axe-compute-names-kyle-okamoto-president-adding-deep-infrastructure-systems-expertise-to-executive-team</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Axe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive Team</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904096687-3-e-network-announces-progress-update-on-finland-ai-data-centre-project-site-clearance-completed-and-earthworks-underway</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:50:00+00:00</news:publication_date>
        <news:title>3 E Network Announces Progress Update on Finland AI Data Centre Project: Site Clearance Completed and Earthworks Underway</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5eebaeed-93ca-4d9b-8fe3-9609a3296bb8/medium/press-release-photo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904092950-organogenesis-holdings-inc-to-report-first-quarter-of-fiscal-year-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:30:00+00:00</news:publication_date>
        <news:title>Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.funafutitechreport.com/article/904092960-medicus-pharma-submits-optimized-phase-2-study-protocol-to-u-s-fda-for-teverelix-in-acute-urinary-retention</loc>
      <news:news>
        <news:publication>
          <news:name>Funafuti Tech Report</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:30:00+00:00</news:publication_date>
        <news:title>Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
